Miranda Jayne Toledano - 01 Jul 2026 Form 4 Insider Report for Journey Medical Corp (DERM)

Reporting relationship: Director
Issuer ticker: DERM
Reported as of: 01 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jul 2026, 16:07:30 UTC
Prior SEC filing: 29 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Ramsey Alloush, attorney-in-fact

Key filing fact

Miranda Jayne Toledano filed Form 4 for Journey Medical Corp (DERM) on 02 Jul 2026.

Key facts

This page summarizes Miranda Jayne Toledano's Form 4 filing for Journey Medical Corp (DERM).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Jul 2026, 16:07.

Change

Previous filing in this sequence was filed on 29 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001686530 Primary reporting owner

Toledano Miranda Jayne

Relationship: Director
Address: C/O JOURNEY MEDICAL CORPORATION, 9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Signature: /s/ Ramsey Alloush, attorney-in-fact
Signature date: 02 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DERM transaction

Common Stock, $0.0001 par value

Award

Transaction value
Shares: +50,000
Change %: +42%
Price: $0.000000^*
Shares after: 168,618
Date: 01 Jul 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On July 1, 2026, the reporting person was granted 50,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 16,666 shares on July 1, 2029, 16,667 shares on July 1, 2030 and 16,667 shares on July 1, 2031.

Footnote F2

Includes restricted stock units, which vest over various time periods.